Canopy Growth has completed the acquisition of MTL Cannabis
The combined company expands Canopy's premium flower supply, enhanced operating execution and ability to meet demand in regulated international medical markets, including Europe. "The acquisition of MTL is a defining step forward in strengthening Canopy Growth's core Canadian business and advancing our path toward sustainable profitability," said Luc Mongeau, Chief Executive Officer, Canopy Growth. "We have long admired MTL and their approach to cannabis and business, and together we are Canada's leading medical cannabis company, complemented by a strong and accelerating adult-use platform within the country. Today, we are better positioned to deliver higher-quality products, operate more efficiently, and scale strategically to meet growing demand in international markets."
"At the heart of this next chapter are our people. We're thrilled to welcome MTL employees to Canopy Growth. Your talent and dedication make this company exceptional, and we're excited to move forward together," continued Mr. Mongeau.
"We're proud to join Canopy Growth and begin this next phase as one team," said Richard Clément, Co-Founder and former Chief Cultivation Officer, MTL Cannabis.
"MTL was built on disciplined operations and a relentless focus on quality. With Canopy Growth's scale and reach, we can continue to bring high-quality product to more medical patients and adult-use consumers in Canada and internationally," added Mike Perron, Chief Operating Officer, Canopy Growth, and former Chief Executive Officer, MTL Cannabis.
For more information:
Canopy Growth Corp.
[email protected]
canopygrowth.com
